Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients. (Q33745000)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Christine Lefebvre

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Norbert Ifrah

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

E Nicolas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

C Ramus

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

S Berthier

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

A Bouamrani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

F Morel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

J Garin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

F Berger

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

J Y Cahn

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

P Mossuz

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

12 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

57-65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

Prognostic factors in acute myeloid leukemia

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

Prognostically useful gene-expression profiles in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

Is proteomics the new genomics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

Proteomics by mass spectrometry: approaches, advances, and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

Proteomic analysis of human acute leukemia cells: insight into their classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

Proteomic analysis of acute myeloid leukemia: Identification of potential early biomarkers and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

The comparative analysis of serum proteomes for the discovery of biomarkers for acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

Proteomic analysis of apoptosis initiation induced by all-trans retinoic acid in human acute promyelocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

Functional proteomic profiling of AML predicts response and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

Induction of C/EBPalpha activity alters gene expression and differentiation of human CD34+ cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

Gene-expression profiling in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

7 January 2021

Independent prognostic factors for AML outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

7 January 2021

S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

7 January 2021

The tumour antigens RAGE-1 and MGEA6 are expressed more frequently in the less lineage restricted subgroups of presentation acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.251

7 January 2021

Identifiers

DOI

10.1038/LEU.2010.251

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072048%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

16 January 2020

1033233286

0 references

1 reference